BEL to Manufacture Indigenous RxT17 Hemodialysis Machine in India
BEL to Make RxT17 Hemodialysis Machine in India

BEL to Manufacture Indigenous RxT17 Hemodialysis Machine in India

In a significant development for India's medical technology sector, Bharat Electronics Limited (BEL) has announced plans to manufacture the RxT17 Hemodialysis machine. This device, designed by Renalyx, represents one of India's first fully indigenous hemodialysis machines, marking a crucial milestone in the nation's efforts to enhance self-reliance in healthcare technology.

Key Details of the RxT17 Hemodialysis Machine

The RxT17 Hemodialysis machine is engineered to provide advanced renal care, offering features that align with global standards for dialysis treatment. Its indigenous design by Renalyx underscores a push towards reducing dependency on imported medical equipment, which can often be costly and subject to supply chain disruptions.

This initiative is expected to bolster India's Medtech capabilities, potentially leading to more affordable and accessible dialysis services across the country. Hemodialysis is a critical procedure for patients with kidney failure, and the availability of domestically produced machines could improve healthcare outcomes and reduce treatment costs.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Impact on India's Medtech Sector

The manufacturing of the RxT17 by BEL is poised to have a transformative effect on India's Medtech landscape. By leveraging BEL's expertise in electronics and defense manufacturing, this project aims to integrate high-quality production processes into the medical device industry.

  • Enhancement of indigenous innovation in healthcare technology.
  • Potential for job creation and skill development in the Medtech field.
  • Strengthening of India's position in the global medical equipment market.

This move aligns with broader government initiatives to promote 'Make in India' in critical sectors like healthcare, ensuring that vital medical devices are produced locally to meet domestic demand and support public health infrastructure.

As of April 2026, this announcement highlights a proactive step towards achieving technological self-sufficiency in medical care, with the RxT17 Hemodialysis machine set to become a cornerstone of India's indigenous medical device portfolio.

Pickt after-article banner — collaborative shopping lists app with family illustration